605 Page 1 20-Oct-2026 Form 605 Corporations Act 2001 Section 671B Notice of ceasing to be a substantial holder To Company Name/Scheme CLARITY PHARMACEUTICALS LTD ACN/ARSN 143 005 341 1. Details of substantial holder (1) Name State Street Corporation and subsidiaries named in paragraph 4 to this...
Ceasing to be a substantial holder
Filed with ASX ·
6ix hasn’t read this filing yet.
Clarity Pharmaceuticals Ltd. on 6ix
Earlier from Clarity Pharmaceuticals
- SAR-bisPSMA Presentation - Drug & Device Conference
- SECuRE update
- Becoming a substantial holder
- Corporate governance statement
- Appendix 4G
Later from Clarity Pharmaceuticals
- Notice of Annual General Meeting/Proxy Form
- Ph III CLARIFY trial target number of participants achieved
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow Clarity Pharmaceuticals into a list and get an email when it puts out news.
Follow Clarity Pharmaceuticals